Cisapride enhances detrusor contractility and improves micturition in a woman with lazy bladder

被引:9
作者
Franceschetti, GP
Candura, SM
Vicini, D
Tonini, M
机构
[1] UNIV PAVIA,DEPT INTERNAL MED & THERAPEUT,DIV PHARMACOL & TOXICOL,I-27100 PAVIA,ITALY
[2] OSPED CIVILE,DIV UROL,VOGHERA,ITALY
[3] UNIV PAVIA,DEPT PREVENT OCCUPAT & COMMUNITY MED,I-27100 PAVIA,ITALY
[4] PAVIA MED CTR,IRCCS,FDN SALVATORE MAUGERI,TOXICOL UNIT,PAVIA,ITALY
来源
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY | 1997年 / 31卷 / 02期
关键词
lazy bladder; detrusor hypocontractility; 5-HT4; receptors; cisapride; treatment;
D O I
10.3109/00365599709070333
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A 32-year-old woman with lazy bladder was treated with cisapride (10 mg q.i.d.) for three weeks, obtaining a progressive improvement of the symptomatology and urodynamic parameters, and the return to pretreatment conditions after drug withdrawal. This case agrees with the evidence that cisapride potentiates the release of acetylcholine from postganglionic cholinergic nerves in the human isolated detrusor by activating 5-HT4 receptors, i.e. through the same mechanism responsible for its gastrointestinal prokinetic action. It is concluded that selective 5-HT4 agonists could be potentially useful to improve bladder emptying in micturition disorders associated with detrusor hypocontractility.
引用
收藏
页码:209 / 210
页数:2
相关论文
共 10 条
[1]  
BOYD IW, 1994, MED J AUSTRALIA, V160, P579
[2]  
CANDURA SM, 1996, IN PRESS BR J PHARM, V118
[3]   EFFECTS OF CISAPRIDE ON CONSTIPATION DUE TO A NEUROLOGICAL LESION [J].
DEGROOT, GH ;
DEPAGTER, GF .
PARAPLEGIA, 1988, 26 (03) :159-161
[4]   TREATMENT WITH CISAPRIDE OF THE GASTROINTESTINAL AND UROLOGICAL SEQUELAE OF SPINAL-CORD TRANSECTION - CASE-REPORT [J].
ETIENNE, M ;
VERLINDEN, M ;
BRASSINNE, A .
PARAPLEGIA, 1988, 26 (03) :162-164
[5]  
FRANCESCHETTI GP, 1995, URODINAMICA, V5, P191
[6]  
Hanson P, 1989, Acta Belg Med Phys, V12, P81
[7]  
MUNDY AR, 1994, URODYNAMICS PRINCIPL
[8]   A RISK-BENEFIT ASSESSMENT OF CISAPRIDE IN THE TREATMENT OF GASTROINTESTINAL DISORDERS [J].
TACK, J ;
COREMANS, G ;
JANSSENS, J .
DRUG SAFETY, 1995, 12 (06) :384-392
[9]  
TONINI M, 1994, BRIT J PHARMACOL, V113, P1
[10]  
Tonini M., 1995, SEROTONIN MODULATION, P53